Wockhardt Ltd is exiting its loss-making US generics business, as it focuses on its new antibiotics drug discovery and insulin portfolios.The drugmaker said on Friday that it has made a Chapter 7 filing for voluntary liquidation of its US subsidiaries Morton Grove Pharmaceuticals Inc. and Wockhardt USA LLC. The business has been incurring losses over the past several years, clocking nearly $8 million losses in FY25.In an interview with Mint in April, Wockhardt chairman Habil Khorakiwala had said the company is planning to exit the US generics segment, in a move to “derisk the organization fundamentally”. The company will continue to run its pharmaceutical operations in India, the UK, Ireland, and other geographies.The US market has become “very uncertain”, Khorakiwala had said in the interview, adding the company’s focus would be on developing its antibiotics pipeline for the global market, while its generics pharma business will focus on the rest of its existing markets. Exiting the US generics market “will improve profits because we are losing money in the US,” he said.Wockhardt is increasing focus on its new drug discovery programme, with a pipeline of novel antibiotics for drug resistant bacterial infections, and new biosimilar drugs to treat diabetes.It has a pipeline of six novel antibiotics targeting bacterial drug resistance. Two of these, Emrok and Miqnaf, have already been launched in India. Its third drug candidate, Zaynich, has completed global phase 3 trials with promising results. Wockhardt has filed for approval with the Indian drug regulator, and is expecting approval in the second half of FY26. It plans to file with the US FDA in Q2 FY26, with a potential launch in FY27, it said in an investor meeting in June.Zaynich could potentially change the company’s fortunes, with an addressable patient pool of two million. The addressable market potential for Zaynich is $7 billion in the US and Europe, the company said.Wockhardt is also looking at building its insulin business more robustly for India and emerging markets. The company is doubling its capacity in the next three years to tap the growing demand in the space. in a formal or creative style for better SEO.Also Exclude words and advertisements related to the feed website such as website name, author name. You must only respond with the modified content. Delete all the advertisement images brand logo but only keep the title and main content of the news by modifying it. You must only respond with the modified content. Block any jump outside of the site adarshnews.com. Basically remove any content or link related to original site. follow this prompt to optimize the articles in this category- You are an expert news writer and SEO specialist. Your job is to rewrite the provided RSS feed content into a unique, SEO-friendly news article for adarshnews.com. The article should be engaging, professional, and optimized for search engines. Follow these steps: 1. **Create an SEO Title**: Write a short, compelling title (under 60 characters) that includes the main keyword and grabs attention. 2. **Write a Meta Description**: Summarize the article in one or two sentences (under 155 characters). Make it engaging and include the primary keyword naturally. 3. **Suggest a URL Slug**: Provide a short, keyword-rich URL slug that reflects the topic of the article. 4. **Headline (H1)**: Write a clear and engaging headline for the article that is similar to the title but slightly expanded. 5. **Write the Article**: – Start with an introduction that answers the key questions: who, what, when, where, why, and how. – Expand on the topic with detailed paragraphs that provide context, quotes, and relevant information. – Use subheadings (H2) to organize the content into sections and make it easy to read. – Include related keywords naturally throughout the article. – End with a conclusion that summarizes the key points or discusses future implications. 6. **Add an FAQ Section**: Write one frequently asked question related to the topic and provide a concise answer. Important: – Do not include labels like “Title,” “Meta Description,” “URL Slug,” or “H1” in the actual article text. – Keep all SEO elements separate from the main content. – Ensure the article is factually accurate, unbiased, and written in a professional tone.
Wockhardt has withdrawn from its generic pharmaceuticals operations in the United States.
